China Transcatheter Aortic Valve Replacement TAVR & Transcatheter Mitral Valve TMV Market Insights & Forecasts 2024-2028 - ResearchAndMarkets.com.

A report titled "China TAVR & TMV Market: Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" has been added to ResearchAndMarkets.com's offerings. The report predicts that the China TAVR market will reach US$4.04 billion by 2028, growing at a CAGR of 55.55% from 2024-2028. The TMV market in China is also expected to rise to US$4515.5 million by 2028, with a CAGR of 146.50% from 2024-2028. Factors driving this growth include the increasing prevalence of aortic stenosis, the approval of new TAVR products, the rise in the geriatric population, and rapid urbanization. However, challenges such as risks associated with TAVR procedures and patient selection in TMVI may hinder market growth. The report also highlights trends such as the rising penetration of TAVR and TMV procedures, declining prices of transcatheter mitral valve procedures, upcoming major TMVI products, and an increase in complications in open-heart surgery. The development of interventional heart valve therapy is considered a safe and minimally invasive treatment for elderly patients with high surgical risks and poor health. The report emphasizes the broadening indications for interventional therapy and the growing number of medical device companies participating in R&D of transcatheter heart valve repair and replacement products in China. The report provides a [Extracted from the article]